AstraZeneca (AstraZeneca) Total Liabilities : $64,792 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Total Liabilities?

AstraZeneca's Total Liabilities for the quarter that ended in Mar. 2024 was $64,792 Mil.

AstraZeneca's quarterly Total Liabilities increased from Sep. 2023 ($58,865.00 Mil) to Dec. 2023 ($61,953.00 Mil) and increased from Dec. 2023 ($61,953.00 Mil) to Mar. 2024 ($64,792.00 Mil).

AstraZeneca's annual Total Liabilities declined from Dec. 2021 ($66,076.00 Mil) to Dec. 2022 ($59,425.00 Mil) but then increased from Dec. 2022 ($59,425.00 Mil) to Dec. 2023 ($61,953.00 Mil).

AstraZeneca Total Liabilities Historical Data

The historical data trend for AstraZeneca's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Total Liabilities Chart

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

46,781.00

51,091.00

66,076.00

59,425.00

61,953.00

AstraZeneca Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															60,876.00	59,127.00	58,865.00	61,953.00	64,792.00

AstraZeneca Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

AstraZeneca's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	30542	+	(23222	+	6669
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	1520)
	=	61,953

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	101119	-	39166
	=	61,953

AstraZeneca's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	28901	+	(28220	+	6391
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	1280)
	=	64,792

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	102293	-	37501
	=	64,792

AstraZeneca Total Liabilities Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (AstraZeneca) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.